Repligen | Себестоимость



Cost Of Sales Изменить Дата
Agilent USD 782M 2M 2025-01
Align Technology USD 298.28M 2.18M 2024-12
Bio Techne USD 100.45M 1.09M 2024-12
BioMarin Pharmaceutical USD 136.14M 52.32M 2024-12
Bristol-Myers Squibb USD 3.03B 179M 2025-03
Bruker USD 486.3M 40.7M 2024-12
Charles River Laboratories USD 682.87M 40.87M 2024-12
Danaher USD 2.23B 418M 2025-03
Dentsply International USD 450M 6M 2024-12
Exact Sciences USD 284.13M 88.06M 2024-12
General Electric USD 6.2B 977M 2025-03
Henry Schein USD 2.2B 17M 2024-12
Illumina USD 376M 41M 2024-12
IQVIA Holdings USD 2.58B 62M 2024-12
Mettler Toledo International USD 405.81M 548.72M 2024-12
Myriad Genetics USD 59.7M 3.8M 2024-12
Pfizer USD 5.65B 781M 2024-12
Repligen USD 87.23M 11.34M 2024-12
Revvity USD 317.08M 17.85M 2024-12
Standard Biotools USD 24.81M 3.1M 2024-12
Thermo Fisher Scientific USD 6.06B 517M 2025-03
Waters USD 348.52M 46.86M 2024-12
West Pharmaceutical Services USD 466.1M 9.1M 2025-03



Repligen Себестоимость - Текущие значения, предыдущие значения, прогнозы, графики и экономический календарь - Apr 2025.